Coloplast Valuation
| CLPBY Stock | USD 12.51 0.41 3.17% |
At this time, the firm appears to be fairly valued. Coloplast A shows a prevailing Real Value of $12.9 per share. The current price of the firm is $12.51. Our model approximates the value of Coloplast A from analyzing the firm fundamentals such as Current Valuation of 28.84 B, profit margin of 0.20 %, and Return On Equity of 0.75 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Coloplast's price fluctuation is not too volatile at this time. Calculation of the real value of Coloplast A is based on 3 months time horizon. Increasing Coloplast's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Coloplast is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Coloplast Pink Sheet. However, Coloplast's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.51 | Real 12.9 | Hype 12.51 | Naive 12.48 |
The intrinsic value of Coloplast's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Coloplast's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Coloplast A helps investors to forecast how Coloplast pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Coloplast more accurately as focusing exclusively on Coloplast's fundamentals will not take into account other important factors: Coloplast Total Value Analysis
Coloplast A is currently forecasted to have takeover price of 28.84 B with market capitalization of 24.94 B, debt of 16.36 B, and cash on hands of 854 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Coloplast fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
28.84 B | 24.94 B | 16.36 B | 854 M |
Coloplast Investor Information
The company last dividend was issued on the 2nd of December 2022. Based on the key indicators related to Coloplast's liquidity, profitability, solvency, and operating efficiency, Coloplast A is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Coloplast Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Coloplast has an asset utilization ratio of 64.59 percent. This suggests that the Company is making $0.65 for each dollar of assets. An increasing asset utilization means that Coloplast A is more efficient with each dollar of assets it utilizes for everyday operations.Coloplast Ownership Allocation
Coloplast holds a total of 2.12 Billion outstanding shares. Almost 99.99 percent of Coloplast outstanding shares are held by general public with 0.01 % by other corporate entities. On June 8, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of Coloplast A's common stock.Coloplast Profitability Analysis
The company reported the revenue of 22.58 B. Net Income was 4.71 B with profit before overhead, payroll, taxes, and interest of 15.53 B.Coloplast Past Distributions to stockholders
About Coloplast Valuation
Our relative valuation model uses a comparative analysis of Coloplast. We calculate exposure to Coloplast's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Coloplast's related companies.Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast is traded on OTC Exchange in the United States.
8 Steps to conduct Coloplast's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Coloplast's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Coloplast's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Coloplast's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Coloplast's revenue streams: Identify Coloplast's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Coloplast's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Coloplast's growth potential: Evaluate Coloplast's management, business model, and growth potential.
- Determine Coloplast's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Coloplast's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
A single share of Coloplast represents a small ownership stake in the entity. As a stockholder of Coloplast, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Coloplast Dividends Analysis For Valuation
Please note that Coloplast has scaled down on payment of dividends at this time.
There are various types of dividends Coloplast can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Coloplast shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Coloplast A directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Coloplast pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Coloplast by the value of the dividends paid out.
Coloplast Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 2.1 B | |
| Quarterly Earnings Growth Y O Y | -0.063 | |
| Forward Price Earnings | 33.3333 | |
| Retained Earnings | 8.6 B |
Additional Tools for Coloplast Pink Sheet Analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.